Dispensing Paxlovid in Community Pharmacies
Nirmatrelvir/ritonavir (Paxlovid™) is an oral antiviral drug used to treat mild-to-moderate COVID-19 in adults who do not require hospitalization and are at high risk of progressing to serious illness.
Nirmatrelvir/ritonavir (Paxlovid™) is an oral antiviral drug used to treat mild-to-moderate COVID-19 in adults who do not require hospitalization and are at high risk of progressing to serious illness.
As the COVID-19 global health pandemic continues to impact nearly every aspect of peoples’ professional and personal lives, health professionals are likely aware of online and social media-driven conversations about the use of anti-malarial, antibiotic and antiviral therapies to treat COVID-19 patients.
There has been various conflicting reports and information about ibuprofen and its effect on people suffering from COVID-19 symptoms. Early reports indicated NSAID drugs could worsen the effects of the virus.
Provincial Health Officer, Dr. Bonnie Henry has issued an order providing criteria and guidance for exempting essential workers from the self-isolation requirements for people who have travelled outside of Canada and returned on or after March 12, 2020.
The order provides self-isolation guidance for essential workers who provide services that are considered critical to preserving life, health, public safety and basic societal functioning and who have been determined by the leadership of their organization to be critical for delivery these essential services.
On March 16, 2020, in a joint statement on B.C.’s COVID-19 response, Minister of Health, Adrian Dix and B.C. Provincial Health Officer, Dr. Bonnie Henry announced that patients will be able to obtain refills of their regular prescriptions at pharmacies in an effort to avoid non-essential physician visits and free doctors to treat COVID-19 cases.